HIV eradication symposium: will the brain be left behind?
- PMID: 25750070
- PMCID: PMC4432099
- DOI: 10.1007/s13365-015-0322-6
HIV eradication symposium: will the brain be left behind?
Abstract
On 18 July 2014, the National Institute of Mental Health in collaboration with ViiV Health Care and Boehringer Ingelheim supported a symposium on HIV eradication and what it meant for the brain. The symposium was an affiliated event to the 20th International AIDS Conference. The meeting was held in Melbourne, Australia, and brought together investigators currently working on HIV eradication together with investigators who are working on the neurological complications of HIV. The purpose of the meeting was to bring the two fields of HIV eradication and HIV neurology together to foster dialogue and cross talk to move the eradication field forward in the context of issues relating to the brain as a potential reservoir of HIV. The outcomes of the symposium were that there was substantive but not definitive evidence for the brain as an HIV reservoir that will provide a challenge to HIV eradication. Secondly, the brain as a clinically significant reservoir for HIV is not necessarily present in all patients. Consequently, there is an urgent need for the development of biomarkers to identify and quantify the HIV reservoir in the brain. Lastly, when designing and developing eradication strategies, it is critical that approaches to target the brain reservoir be included.
Similar articles
-
HIV Eradication Strategies: Implications for the Central Nervous System.Curr HIV/AIDS Rep. 2019 Feb;16(1):96-104. doi: 10.1007/s11904-019-00428-7. Curr HIV/AIDS Rep. 2019. PMID: 30734905 Free PMC article. Review.
-
How to best measure HIV reservoirs?Curr Opin HIV AIDS. 2013 May;8(3):170-5. doi: 10.1097/COH.0b013e32835fc619. Curr Opin HIV AIDS. 2013. PMID: 23564004 Free PMC article. Review.
-
HIV-1: towards understanding the nature and quantifying the latent reservoir.Acta Virol. 2020;64(1):3-9. doi: 10.4149/av_2020_101. Acta Virol. 2020. PMID: 32180413
-
The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication.Curr HIV/AIDS Rep. 2015 Jun;12(2):299-303. doi: 10.1007/s11904-015-0257-9. Curr HIV/AIDS Rep. 2015. PMID: 25869939 Review.
-
Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol.BMJ Open. 2019 Apr 20;9(4):e028444. doi: 10.1136/bmjopen-2018-028444. BMJ Open. 2019. PMID: 31005944 Free PMC article.
Cited by
-
HIV latency reversal research and the potential effects on the central nervous system: is concern warranted?J Int AIDS Soc. 2016 May 9;19(1):21008. doi: 10.7448/IAS.19.1.21008. eCollection 2016. J Int AIDS Soc. 2016. PMID: 27166355 Free PMC article. No abstract available.
-
HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cART.J Virus Erad. 2018 Jan 1;4(1):41-47. doi: 10.1016/S2055-6640(20)30243-0. J Virus Erad. 2018. PMID: 29568553 Free PMC article.
-
Targeting the Brain Reservoirs: Toward an HIV Cure.Front Immunol. 2016 Sep 30;7:397. doi: 10.3389/fimmu.2016.00397. eCollection 2016. Front Immunol. 2016. PMID: 27746784 Free PMC article. Review.
-
Circulating levels of ATP is a biomarker of HIV cognitive impairment.EBioMedicine. 2020 Jan;51:102503. doi: 10.1016/j.ebiom.2019.10.029. Epub 2019 Dec 3. EBioMedicine. 2020. PMID: 31806564 Free PMC article.
-
In situ analysis of neuronal injury and neuroinflammation during HIV-1 infection.Retrovirology. 2024 Jul 1;21(1):11. doi: 10.1186/s12977-024-00644-z. Retrovirology. 2024. PMID: 38945996 Free PMC article.
References
-
- An SF, Groves M, Giometto B, Beckett AA, Scaravilli F. Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neuropathol. 1999;98(5):481–487. - PubMed
-
- Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE. Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol. 2005;64(6):529–536. - PubMed
-
- Archin NM, Liberty AL, Kashuba AD, Choudhary SK, Kuruc JD, Crooks AM, Parker DC, Anderson EM, Kearney MF, Strain MC, Richman DD, Hudgens MG, Bosch RJ, Coffin JM, Eron JJ, Hazuda DJ, Margolis DM. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature. 2012;487(7408):482–485. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical